The effective introduction psycho bears gummies tutankhamon marijuana
Two drugs containing the synthetic component THC have recently been approved in the US. Dronabinol is a combination of the synthetic compound THC and sesame oil. Most of the active ingredient is absorbed during digestion, but only 10-20% of the initial dose goes to the blood. In the preparation nabilon contains a slightly different version of synthetic THC, which enters the bloodstream in larger quantities. A common problem with these two drugs is that they are slow and the amount of active ingredient entering the bloodstream varies from patient to patient.
Another drug being tested in the USA (and already approved for sale in Canada) is a combination of THC and cannabidiol. Approved for sale in Canada, this drug is sometimes referred to as "liquid hashish" because it is sprayed in the mouth using a small portable device. However, the effects take some time to develop as the drug must penetrate the oral tissue before it enters the systemic bloodstream.
Inhalation (inhalation) is the fastest way to get THC into the bloodstream, so patients may find smoking to be their preferred route of administration. However, although this method has a quick effect by smoking marijuana, the patient exposes themselves to many unexplored chemicals and their lungs to the same risk as when smoking cigarettes. Limited research evidence suggests that evaporators can reduce the amount of harmful chemical compounds that enter the lungs during inhalation.
A review of the side effects caused by medical marijuana shows that most of them are non-intensive, "soft". Compared to the control group, people who use marijuana for medical purposes were at increased risk of pneumonia and other respiratory diseases, and suffered from nausea and gastrointestinal disorders.
It is clear that recreational use of marijuana leads to short-term cognitive problems, including impaired thinking, working memory, executive functions (ability to concentrate and integrate different types of information). Despite the paucity of scientific evidence on medical use of marijuana, informal reports indicate that many people use marijuana at night to avoid cognitive problems and associated life and social consequences.
There is debate about whether prolonged use of marijuana (for both recreational and medical purposes) leads to permanent, sustained cognitive impairment. Although early research on this issue in Germany clearly indicated the presence of such disorders, there were design problems during the course of the research. They usually compared regular marijuana smokers with years of experience with people who had never used marijuana without taking into account the background characteristics of the persons studied. Indicators such as level of education, mental development and others that indicate who will continue to smoke "weed" and who may be at greatest risk of developing thinking and memory problems in the future were ignored.
Recent research shows that while overall cognitive abilities remain the same, prolonged marijuana use can cause subtle but persistent executive dysfunctions, including concentration, associative thinking and analysis of large amounts of information. On the other hand, it is difficult to determine the significance of the impact of these tutankhamon marijuana impairments on a person's ability to function adequately in society.
Thus, more research is needed that focuses on the benefits and consequences of medical marijuana use in individual mental disorders. The results will help to clarify some of the issues concerning the interaction of marijuana, the brain and the human psyche.
It should be noted that to date there is insufficient evidence, both research and clinical, to recommend marijuana or its individual chemical psycho bears gummies components as an alternative treatment for any psychiatric condition.